Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.
about
Methods for analyzing observational longitudinal prognosis studies for rheumatic diseases: a review & worked example using a clinic-based cohort of juvenile dermatomyositis patients.Defining Low Disease Activity in Systemic Lupus Erythematosus.Clinical manifestations and survival among adults with (SLE) according to age at diagnosis.Systemic lupus erythematosus: review of synthetic drugs.Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus-the Hopkins Lupus CohortOrgan damage in high-risk patients with systemic and incomplete lupus syndromesFrequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort.Damage in the Multiethnic Malaysian Systemic Lupus Erythematosus (SLE) Cohort: Comparison with Other Cohorts WorldwidePrognosis for Hospitalized Patients with Systemic Lupus Erythematosus in China: 5-Year Update of the Jiangsu Cohort.Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence.Prediction of chronic damage in systemic lupus erythematosus by using machine-learning modelsLatest advances in connective tissue disorders.Association of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the Georgians Organized Against Lupus study.Differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis with complements C3 and C4 and C-reactive protein.Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials.Independent association of glucocorticoids with damage accrual in SLE.Development of the Systemic Lupus Erythematosus Steroid Questionnaire (SSQ): a novel patient-reported outcome tool to assess the impact of oral steroid treatment.Update on differences between childhood-onset and adult-onset systemic lupus erythematosus.Use of SLICC criteria in a large, diverse lupus registry enables SLE classification of a subset of ACR-designated subjects with incomplete lupus.Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.Organ damage in patients with incomplete lupus syndromes: from a Chinese academic center.Optimizing the use of existing therapies in lupus.Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.Why are kids with lupus at an increased risk of cardiovascular disease?Development and validation of a clinical HPLC method for the quantification of hydroxychloroquine and its metabolites in whole blood.Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.Why targeted therapies are necessary for systemic lupus erythematosus.Possible risk factors associated with greater damage in systemic lupus erythematosus patients: an Egyptian multicenter study.Systemic lupus erythematosus diagnosis and management.It hasn't gone away: the problem of glucocorticoid use in lupus remains.Cutaneous characteristics and association with antinuclear antibodies in 402 patients with different subtypes of lupus erythematosus.Treatment pathways in an inception lupus cohort over the first three years.The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.Is chronic periodontitis premature in systemic lupus erythematosus patients?Epidemiology and risk factors for chronic kidney disease in Chinese patients with biopsy-proven lupus nephritis.Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE.Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus.Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years.Factors Related to Blood Hydroxychloroquine Concentration in Patients With Systemic Lupus Erythematosus.A descriptive study of the factors associated with damage in Malaysian patients with lupus nephritis.
P2860
Q30235042-B482A0FD-8CE3-42B7-A7CF-7E2066C71105Q33435736-99386BCD-243F-48A8-BEDA-E73479E7B3BDQ34146671-84EAAEB8-F5A1-48B2-8DAC-05040724D050Q34498515-7D9B2744-FCFF-470D-A11F-952CD0B0A2C4Q35229284-C6869373-9F33-454E-8AF1-03CCA52619BBQ35600608-1E086634-1CDE-4719-9192-64E01590ED62Q36188027-C53E5FF0-07F9-4AE0-8A30-D38D27D6043AQ36192962-D5488D44-9877-4BB5-9222-A2852D76EAA3Q36234766-8E909D7E-847C-438E-85E6-DB3C15F47B20Q36240425-99E20D10-A086-4FD5-840C-E1552AC861ADQ36318533-FB37F6DD-B23A-4FDA-9340-B17657929F5DQ37058776-13D59C29-A3C8-416F-86D8-CD858F0DA240Q37133875-B37B8D03-3633-4EAC-9416-46A9E9C38D9EQ37289115-7E4C3F94-7411-49E2-BD20-37ABCA643EACQ37456307-52481B54-6F2A-47C2-B160-8267F209A6D4Q37464030-CD41411B-417B-4AE5-A2FB-27D00A75BB80Q37673352-C47914A9-4721-46BC-94BB-D8FE6E3B9700Q37690103-44F7DCBB-7B5C-449D-9D3C-655B554FB066Q37728453-FD1E2199-840E-4446-BB33-A16E35B6FD7CQ38205079-031FF697-C04D-4AF7-A6E0-0938EB2FA349Q38357991-AAE0BD49-788F-42DD-B7B3-CEBCBC2D7AD4Q38425824-A855E412-1086-4FDF-820C-F070AE01ECD7Q38561490-399AE4E4-CBD4-4119-A3C5-CB4B50A839F2Q38591752-ADA54072-D634-470D-902A-CCED9CE4D57CQ38776952-1EBBEB0A-DB9F-47C1-A275-B57BBAF41BDFQ38800659-F84699F3-61FC-4F3E-B5B4-FED97486BAB4Q38920435-4D563658-706D-4C63-BFFB-DEDA25D4D914Q39043294-846C340B-A1FE-40CC-AA52-ECF7C4494E11Q39053129-07B64F66-C22A-44A4-94F5-77DCE1B0966BQ39053147-D1E1DE83-319D-4A6B-9F81-27763EFE5CD1Q39587357-29DB3375-B0A6-4160-B1C5-DA79D52B88DDQ39640596-B1A8F2D7-1F70-4C5D-83CB-7DAB60DDE1B5Q40047382-11CABB3A-38CC-42DB-9798-E48DD08398ACQ40608767-3A78C0C4-9D42-4E52-B145-91F3E14922FFQ40799533-49A557DD-D7B1-4269-A3C5-28C6F4F328BFQ41317956-1D08415B-6C21-4568-931F-1C2D4A366028Q41680597-B8C44934-4E70-4A00-8A85-D1D06C897D2EQ41698087-BF0A22B7-765C-4831-9196-EC172A3DC241Q41914711-0978C971-3ADA-4279-B18A-B1D3E98742A4Q41922844-1A944895-DDD2-4F01-8AA2-9FEEA2ACBC84
P2860
Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.
@ast
Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.
@en
type
label
Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.
@ast
Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.
@en
prefLabel
Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.
@ast
Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.
@en
P2093
P2860
P356
P1476
Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.
@en
P2093
Laurence S Magder
Sneha Purvey
P2860
P304
P356
10.1002/ART.34672
P577
2012-12-01T00:00:00Z